Impact BioMedical Inc.
IBO
$0.8569
-$0.0731-7.86%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 465.66% | 30.81% | -46.42% | 63.27% | 48.97% |
| Total Depreciation and Amortization | 100.00% | -50.00% | 0.00% | 100.24% | -99.88% |
| Total Amortization of Deferred Charges | 0.00% | 0.00% | 0.00% | -75.02% | 150.18% |
| Total Other Non-Cash Items | -37,740.00% | -96.91% | 81.25% | -101.17% | -101.26% |
| Change in Net Operating Assets | -161.50% | -158.88% | 101.35% | 8.73% | 4,420.00% |
| Cash from Operations | -91.51% | 9.14% | 29.78% | -19.28% | 16.33% |
| Capital Expenditure | -- | -- | -- | 100.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00% | -- | 0.00% | 100.00% |
| Cash from Investing | 200.00% | 109.09% | -- | 100.36% | 0.00% |
| Total Debt Issued | -74.25% | -10.86% | -29.89% | -56.96% | 12.55% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 354.02% | -10.86% | -29.89% | -56.96% | 12.55% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,246.46% | -100.00% | 200.00% | -102.02% | 760.00% |
